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ABSTRACT Cyclic -sheet decapeptides from the tyrocidine group and the homolo-
gous gramicidin S were the ﬁrst commercially used antibiotics, yet it remains unclear
exactly how they kill bacteria. We investigated their mode of action using a bacterial
cytological proﬁling approach. Tyrocidines form deﬁned ion-conducting pores, induce
lipid phase separation, and strongly reduce membrane ﬂuidity, resulting in delocalization
of a broad range of peripheral and integral membrane proteins. Interestingly, they also
cause DNA damage and interfere with DNA-binding proteins. Despite sharing 50% se-
quence identity with tyrocidines, gramicidin S causes only mild lipid demixing with mi-
nor effects on membrane ﬂuidity and permeability. Gramicidin S delocalizes periph-
eral membrane proteins involved in cell division and cell envelope synthesis but
does not affect integral membrane proteins or DNA. Our results shed a new light on
the multifaceted antibacterial mechanisms of these antibiotics and explain why resis-
tance to them is virtually nonexistent.
IMPORTANCE Cyclic -sheet decapeptides, such as tyrocidines and gramicidin S,
were among the ﬁrst antibiotics in clinical application. Although they have been
used for such a long time, there is virtually no resistance to them, which has led to
a renewed interest in this peptide class. Both tyrocidines and gramicidin S are thought
to disrupt the bacterial membrane. However, this knowledge is mainly derived from
in vitro studies, and there is surprisingly little knowledge about how these long-
established antibiotics kill bacteria. Our results shed new light on the antibacterial
mechanism of -sheet peptide antibiotics and explain why they are still so effective
and why there is so little resistance to them.
KEYWORDS antibiotics, antimicrobial peptides, bacterial cell biology, bacterial
cytological proﬁling, cell membranes, mode of action
Cyclic -sheet peptides produced by soil bacilli were among the very ﬁrst antibioticsubstances in clinical application and are still used today. One of the most impor-
tant pioneering antibiotics was tyrothricin, a mixture of polypeptide antibiotics pro-
duced by Brevibacillus parabrevis (1). Although discovered 10 years after penicillin,
tyrothricin was actually the ﬁrst antibiotic preparation that was commercially produced
for clinical use, 2 years before penicillin became commercially available. In fact, the
success of tyrothricin inspired the reinvestigation of penicillin as a potential antibiotic
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drug, after penicillin had been deemed unstable, difﬁcult to produce, and of no medical
interest (2). Two years after the commercialization of tyrothricin, gramicidin S was
discovered in the Soviet Union, where it was extensively used to treat gunshot wounds
inﬂicted on the battleﬁelds of World War II (3). Gramicidin S belongs to the same
antibiotic class as tyrothricin but is produced by Aneurinibacillus migulanus (4). Both
compounds display strong hemolytic potential and are limited to topical applications
but are still used today, e.g., for superﬁcial skin and throat infections (5–10). The
imminent public health threat posed by multidrug-resistant microbial pathogens has
rejuvenated investigations of these topical antibiotics for new medical applications.
One of the major components of tyrothricin is the tyrocidines, cyclic -sheet decapep-
tides (Fig. 1A and B) (4) with potent activity against several important pathogens,
including the Gram-positive bacterium Listeria monocytogenes (11, 12), the pathogenic
fungus Aspergillus fumigatus (13) and yeast Candida albicans (14), and the human
malaria parasite Plasmodium falciparum (15). Thus, they have promising potential for
broader applications than the current usage of tyrothricin. Gramicidin S, which shares
50% sequence homology with the tyrocidines (Fig. 1C), is highly active against Gram-
positive staphylococci and enterococci, as well as Gram-negative Escherichia coli and
Pseudomonas aeruginosa (16). This remarkable potency, and the fact that there is
virtually no resistance to these old peptide antibiotics (17), has sparked a renewed
interest in extending their clinical applications (9, 18), and considerable efforts have
been undertaken to develop analogues with lower hemolytic potential (12, 19–25).
Despite this renewed attention, there is very little information on how exactly
tyrocidines kill bacteria (15, 26). Based on an early in vitro study using artiﬁcial
FIG 1 Peptides used in this study and their effects on the growth of B. subtilis. (A to C) Tyrocidine A (A), tyrocidine C (B), and gramicidin S (C) (left panels, skeletal
structure models; right panels, stick models). Tyrocidines consist of a conserved cyclic decapeptide structure of the consensus sequence cyclo(D-Phe1-Pro2-
X3-D-X4-Asn5-Gln6-Tyr7-Val8-Orn9-Leu10). Analogues of the tyrocidines containing either Phe3-D-Phe4, Trp3-D-Phe4, or Trp3-D-Trp4 at the variable dipeptide unit
X3-D-X4 (red) are referred to as tyrocidine A, B, or C, respectively. Gramicidin S [cyclo(Val8-Orn9-Leu10-D-Phe1-Pro2)2] is composed of two repeat moieties of the
conserved pentapeptide sequence of the tyrocidines (blue). Three-dimensional structures of the peptides are derived from the work of Munyuki et al. (93)
(tyrocidines) and Stern et al. (99) (gramicidin S). (D) Growth of B. subtilis exposed to 1 MIC of the peptides (5.4 g/ml tyrocidine A, 2.7 g/ml tyrocidine C,
and 1 g/ml gramicidin S). Cells were grown until early exponential phase prior to addition of compounds. The arrow indicates the time point chosen for further
mode-of-action analysis (10 min).
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liposomes, it is assumed that tyrocidines permeabilize membranes, induce lipid phase
separation, and increase ﬂuidity of the hydrocarbon part of the lipid bilayer (26). How
these effects are achieved and whether these observations are relevant for the in vivo
situation are unknown. Studies with L. monocytogenes and the ﬁlamentous plant fungi
Fusarium solani and Botrytis cinerea conﬁrmed membrane permeabilization by tyroci-
dines (11, 27). However, there is evidence that these peptides also target -glucans in
the fungal cell wall (27), suggesting that there is more to their antimicrobial activity
than only membrane disruption. Importantly, there is almost no further information
available on how these peptides act on bacterial cells, although they have been
clinically used against bacterial infections since 1940 (2). Early studies showed a
reduced oxygen consumption in tyrocidine-treated Staphylococcus aureus (28), and
inhibition of certain NADH-utilizing enzymes of the tyrothricin producer strain (29), but
this has not been followed up.
In contrast to the tyrocidines, the interaction of gramicidin S with model membrane
systems has been well investigated, and the consensus is that the drug partitions into
the membrane at the interface between phospholipid head groups and fatty acid
chains, thereby disturbing lipid packing, leading to membrane collapse at high con-
centrations (30–32). However, there is an ongoing dispute on whether it forms discrete
pores or destroys the membrane in a detergent-like manner and whether membrane
permeabilization occurs at all at concentrations relevant for bacterial killing (31, 33–37).
Unfortunately, since the majority of early studies on gramicidin S were performed in the
middle of the 20th century in the Soviet Union, most reports are available only in
Russian and not easily accessible to the international scientiﬁc community. One of these
early studies described inhibition of proteins in the membrane of its producer strain
(38), and recently, it was shown that gramicidin S interferes with the membrane binding
of the cell wall synthesis enzyme MurG and the electron transport chain protein
cytochrome c (39). It has also been reported that both gramicidin S and the tyrocidines
bind to DNA in vitro, suggesting an alternative or additional killing mechanism (40–43).
The structural homology of gramicidin S and tyrocidines suggests that these peptide
antibiotics kill bacteria in the same way. To investigate this, we performed an in vivo
mode-of-action study employing a recently established bacterial cytological proﬁling
method that makes use of a broad array of ﬂuorescently labeled proteins (44). This
study revealed that tyrocidines and gramicidin S kill bacteria by surprisingly different
mechanisms.
RESULTS
Cell wall integrity. To assess whether the variable aromatic dipeptide unit of the
tyrocidine peptides makes a difference for their in vivo mechanism, we used both
tyrocidine A (Phe3-D-Phe4) and tyrocidine C (Trp3-D-Trp4) (Fig. 1A and B). The tyrocidines
have been proposed to bind to fungal cell wall components (27), and gramicidin S was
shown to affect cell wall integrity in Bacillus subtilis (37). To study how effectively these
antibiotics weaken the bacterial cell wall and cause lysis, we followed the optical
density (OD) of B. subtilis cells treated with MICs of the compounds (Fig. 1D). At this
concentration, a fraction of the tyrocidine-treated cells lysed after 15 to 20 min of
treatment but the culture recovered after approximately 60 min. Gramicidin S treat-
ment did not lead to cell lysis but completely halted further growth. However, at 2
MIC, all three peptides caused lysis and no regrowth could be observed (see Fig. S1 in
the supplemental material). Such cell lysis suggests that these antibiotics somehow
affect the integrity of the cell wall. Since we wanted to analyze the immediate
growth-inhibiting effects of the peptides, instead of pleiotropic lysis effects, we per-
formed further experiments after 10 min of treatment with 1 MIC (unless otherwise
noted), when no strong reduction of the optical density was observed (Fig. 1D).
To further examine the effects on cell wall integrity, we employed an organic
ﬁxation method that is indicative of holes in the peptidoglycan layer, typically related
to impaired synthesis of the cell wall precursor lipid II (45). In line with an earlier study
(39), gramicidin S clearly affected cell wall integrity as seen from the protoplast
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protruding through cell wall breaches (Fig. 2A). However, this phenotype was not
observed for tyrocidines A and C, suggesting a clear mechanistic difference from
gramicidin S. In fact, transmission electron microscopy revealed that the tyrocidines
caused severe cellular damage, intracellular content leakage, and lysis of cells, whereas
gramicidin S-treated cells showed only subtle cell shape alterations but no major signs
of lysis or physical cell damage (Fig. 2B).
Membrane permeability. The current belief is that both the tyrocidines and
gramicidin S form pores in the cell membrane (26, 31, 33–37). However, for the
tyrocidines this has actually never been shown in bacteria, and the pore-forming ability
of gramicidin S is heavily disputed (31, 33–37). Therefore, we examined the effects of
these peptides on membrane permeability in detail. First, we determined the effects of
the peptides on the membrane potential using the membrane potentiometric dye
DiSC(3)5. Tyrocidines A and C led to immediate strong depolarization of B. subtilis cells
already at 0.5 MIC (Fig. 3A). Inhibitory concentrations of gramicidin S (1 MIC) only
gradually and partially depolarized B. subtilis cells. Full depolarization was achieved only
at 2 MIC, a concentration causing cell lysis (Fig. S1). These results suggest that the
tyrocidines form membrane pores while gramicidin S does not.
To further characterize the ability of the peptides to generate distinct ion-
conducting pores, we performed in vitro conductivity measurements. This allowed us to
follow single-ion current events in a planar model lipid system mimicking Gram-
positive membranes (3:1 mixture of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol
[POPG] and 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine [POPE]). In line
with our in vivo data, we observed a number of conductivity events for tyrocidines A
and C at low, nanomolar concentrations (Fig. 4A). Current transitions peaked at 2 pA for
tyrocidine A and 3.5 pA for tyrocidine C, corresponding to calculated conductance
values of 20 pS and 35 pS, respectively (Fig. 4B). These conductance events are
representative of several single-membrane pores that stay open for up to several
seconds. Conductance events induced by gramicidin S were observed only at concen-
trations leading to membrane collapse (5 M, Fig. 4A), lasted only milliseconds, and
exhibited a broad range of amplitudes (Fig. 4A), which is indicative of general bilayer
distortion. Similar behavior has been reported for gramicidin S in diphytanoyl phos-
pholipid bilayers (31). These results show that both tyrocidine A and tyrocidine C
FIG 2 Effects of tyrocidines and gramicidin S on the cell wall. (A) Impact on cell wall integrity. B. subtilis 168 was treated with peptides for 10 min and
subsequently ﬁxed in a 1:3 mixture of acetic acid and methanol. This ﬁxation method leads to extraction of the protoplast through holes in the peptidoglycan
layer (arrow) when synthesis of the cell wall precursor lipid II is impaired (37, 45). Since this ﬁxation method can sometimes lead to quick lysis of heavily
damaged cells, we examined both 0.5 MIC (nonlytic) and 1 MIC of the tyrocidines but did not ﬁnd membrane extrusions under both conditions. Bar, 2 m.
(B) Transmission electron microscopy pictures of B. subtilis 168 treated with 1 MIC of the peptides for 10 min. Bar, 0.5 m.
Wenzel et al. ®
September/October 2018 Volume 9 Issue 5 e00802-18 mbio.asm.org 4
 o
n
 M
ay 9, 2019 by guest
http://m
bio.asm
.org/
D
ow
nloaded from
 
induce discrete long-lived ion-conducting pores, while gramicidin S did not exhibit
pore-forming capacity in our system.
To gain insight into whether tyrocidine pores are small ion channels or large
membrane pores that allow big organic molecules to pass through, pore formation was
assessed by following the inﬂux of the ﬂuorescent dye propidium iodide, which enters
bacterial cells only through membrane lesions large enough for the bulky molecule to
pass (46). Both tyrocidine A and tyrocidine C rapidly formed large pores in B. subtilis
cells (Fig. 3B). Cells treated with gramicidin S did not show any propidium iodide inﬂux,
not even at bacteriolytic concentrations (2 MIC) (Fig. 3B; Fig. S1).
Taken together, both in vivo (Fig. 1 to 3) and in vitro (Fig. 4) experiments strongly
indicated that at inhibitory concentrations tyrocidines A and C, but not gramicidin S,
form large, ion-conducting pores. The slow and incomplete depolarization by grami-
cidin S (Fig. 3A) suggests rather a limited increase of passive membrane permeability.
Membrane protein localization. At MICs, gramicidin S did not fully depolarize the
cell membrane (Fig. 3A) and even at supra-MICs, it did not lead to large membrane
lesions (Fig. 3B). It is therefore plausible that other vital processes must be disturbed
that, together with limited depolarization and impairment of the cell wall (Fig. 2A and
3A), will eventually lead to cell death. It is also well known that the membrane potential
FIG 3 Tyrocidines but not gramicidin S form membrane pores in vivo. (A) Membrane potential
measurements of exponentially growing B. subtilis 168 cells using the membrane potential-sensitive
ﬂuorescent probe DiSC(3)5. Tyrocidines A and C were applied at 0.5 and 1 MIC, and gramicidin S was
applied at 1 and 2 MIC. The red arrow indicates the time point of antibiotic addition. (B) Membrane
permeability for propidium iodide. Exponentially growing cells were treated with peptides for 5 min. For
the tyrocidines, 0.5MIC (nonlytic) and 1MIC were used; gramicidin S was applied at 2MIC (2 g/ml,
lytic concentration). SDS at 0.01% served as a positive control. Strain, B. subtilis 168. au, arbitrary units.
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is required for the localization of peripheral membrane proteins involved in cell division
and cell morphology (47), and pore formation by the tyrocidines is likely to affect
different essential cellular processes. To investigate whether insertion of gramicidin S
and the tyrocidines affects membrane proteins differently, we examined the localiza-
tion of ﬂuorescent membrane protein fusions involved in a variety of cellular processes.
Figure 5A shows peripheral membrane proteins that can be used as reporters for
dissipation of the membrane potential. The cell division proteins MinD and DivIVA
require the membrane potential for their localization at the membrane (44, 47), while
localization of the phospholipid synthase PlsX is independent of the proton motive
force (44). In line with membrane depolarization, all three peptides delocalized MinD
and DivIVA, whereby the tyrocidines caused a more diffuse cytoplasmic ﬂuorescence
signal, while gramicidin S induced stronger clustering of the proteins at the cell
periphery (Fig. 5A). Interestingly, the phospholipid synthase PlsX completely lost its
membrane localization after treatment with both the tyrocidines and gramicidin S.
Since PlsX does not depend on the membrane potential, its delocalization demon-
strates that the peptides have other effects on the membrane than only interfering with
the barrier function of the cell membrane.
The cell wall-damaging effect of gramicidin S has been attributed to detachment of
the peripheral peptidoglycan synthesis enzyme MurG, involved in the last steps of lipid
FIG 4 Conductivity measurements in model membranes. (A) Conductivity measurements in POPG-POPE
(3:1) planar model membranes with an artiﬁcial transmembrane potential of 100 mV. Representative
recordings of single-channel currents of tyrocidine A and tyrocidine C are shown. No ion conductance
events were observed for gramicidin S up to concentrations leading to membrane collapse (5 M). Note
the different peptide concentrations and the different y scales. (B) Single-channel current transition
amplitude histograms of tyrocidine A (gray) and tyrocidine C (red) in POPG-POPE (3:1) membranes
recorded at 100 mV. Normalized frequency refers to the number of times that a pore with a speciﬁc
current amplitude was observed and is displayed as a fraction of the maximum count. Data from 8
independent membranes and 158 single-channel transitions for tyrocidine A and 12 independent
membranes with 560 single-channel transitions for tyrocidine C are shown.
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II synthesis (39). To test whether the localization of this protein and other cell wall
synthesis proteins is affected by the tyrocidines, we examined the localization of MurG,
the transmembrane lipid I synthase MraY, and the actin homologue MreB, which
coordinates lateral peptidoglycan synthesis (48, 49). As shown in Fig. 5B, MurG com-
pletely lost its membrane localization after treatment with all three peptides. However,
MraY was clustered into huge foci by tyrocidines A and C, while gramicidin S did not
show a clear effect. MreB is known to delocalize after membrane depolarization (47, 50).
After treatment with the tyrocidines and, to a lesser extent, also with gramicidin S,
MreB localized into discrete clusters distributed all over the cell membrane (Fig. 5B), a
peculiar effect not seen before with membrane-targeting antibiotics (44, 47, 50).
The actin homologue MreB has been implicated in the formation of ﬂuid membrane
microdomains, so-called regions of increased ﬂuidity (RIFs), which play a role in spatial
organization of cell envelope synthesis (44, 50, 51). This made us curious whether the
peptides would also affect the distribution of bacterial ﬂotillin proteins involved in the
formation of speciﬁc rigid membrane domains (known as lipid rafts in eukaryotes) (52,
53). While the integral ﬂotillin FloA was not affected by any of the peptides, the
peripheral ﬂotillin FloT was clearly detached from the membrane by tyrocidines A and
C but not by gramicidin S (Fig. 5C). FloT interacts with many membrane-associated
proteins (54), and the separation from its interaction partners by dissociation from the
membrane is likely to affect multiple cellular processes, including membrane organi-
zation, ﬂuidity, respiration, protein secretion, membrane transport, signal transduction,
and autolysin activity (53, 56–58).
Since gramicidin S was shown to reduce ATP levels in B. subtilis (39) and tyrocidines
reduced oxygen consumption in S. aureus (28), we also examined their effects on the
FIG 5 Delocalization of membrane proteins labeled with GFP. (A) Reporter proteins for membrane depolarization. Membrane
localization of MinD and DivIVA requires the membrane potential, whereas membrane binding of the peripheral membrane
protein PlsX is independent of the membrane potential. (B) Localization of proteins associated with cell wall synthesis. In
contrast to MreB, localization of the peripheral MurG and integral MraY proteins is not reliant on the membrane potential. (C)
Localization of ﬂotillins involved in the organization of lipid rafts. FloA is an integral membrane protein, and FloT is a peripheral
membrane-associated protein. (D) Localization of proteins involved in membrane-bound energy generation. AtpA and SdhA
are the peripheral subunits of the ATP synthase and succinate dehydrogenase, respectively. Arrowheads indicate regions from
which AtpA and SdhA are fully excluded. B. subtilis strains were grown in LB with appropriate inducer concentrations (see
Table S1) and treated with peptides in early exponential growth phase for 10 min. Bar, 2 m.
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localization of AtpA, the peripheral subunit of the ATP synthase, and SdhA, the ﬂavoprotein
subunit of the succinate dehydrogenase (complex II) of the respiratory chain. These
transmembrane protein complexes are unaffected by membrane potential-dissipating
drugs like carbonyl cyanide m-chlorophenylhydrazone (CCCP) and valinomycin, and
also the membrane-targeting antibiotic daptomycin (44, 47). Surprisingly, both AtpA
and SdhA partially lost their membrane association after treatment with the tyrocidines
(Fig. 5D), explaining inhibition of electron transport chain enzymes reported in an early
study (29, 59). In contrast, gramicidin S had no marked effect on the localization of
these proteins, suggesting that its effect on cellular ATP levels is probably due to
delocalization of cytochrome c (39) and partial membrane depolarization.
Gel-phase domains. Interestingly, many of the tyrocidine-treated cells displayed
large areas from which AtpA and SdhA were excluded (Fig. 5D, arrowheads; Fig. S2, left
panels; and Fig. S3A). It seems as if these empty areas might have been caused by
plasmolysis of the cell membrane due to partial release of cytoplasmic content.
However, the corresponding phase-contrast images did not indicate that these were
partially empty cells (Fig. 5D and Fig. S2, right panels). To examine the effects of the
peptides on the cell membrane in more detail, we employed superresolution structured
illumination microscopy (SIM) and stained the cell membrane with MitoTracker green,
a very bright ﬂuorescent membrane stain that provides excellent SIM contrast (60). As
shown in Fig. 6A, a 10-min incubation with the tyrocidines resulted in strongly
ﬂuorescent foci (open arrows) but also regions that were completely unstained (closed
arrows). Gramicidin S-treated cells did not cause gaps in the ﬂuorescent membrane
stain but some small ﬂuorescent membrane foci. When we expressed green ﬂuorescent
protein (GFP), it became apparent that many of the tyrocidine-treated cells lost their
cytosolic GFP signal (Fig. 6B), indicating leakage of cellular content. Cells were coun-
terstained with the red ﬂuorescent membrane dye Nile red, which showed similar gaps
in its ﬂuorescent stain (Fig. 6B) as observed with MitoTracker green (Fig. 6A). Impor-
tantly, these gaps were also observed in cells that still contained their cytoplasmic GFP
(Fig. 6B and Fig. S3B), indicating that these gaps are not caused by the absence of cell
membrane due to lysis. The only remaining explanation for the absence of both
ﬂuorescent membrane dyes as well as membrane proteins is that these membrane
areas are in a rigid, gel-phase state that excludes most dyes and proteins (61). Although
stabilization of gel-phase domains by antimicrobial peptides has been observed in vitro
(62, 63), to the best of our knowledge, such domains have not been documented
before in bacterial cells.
Accumulation of membrane material. Cells stained with membrane dyes and
treated with gramicidin S, and especially with tyrocidines A and C, showed membrane
patches that were highly ﬂuorescent (Fig. 6A and B and Fig. S3B and C). In the case of
the tyrocidines, these membrane patches seemed to partially displace the cytoplasmic
GFP signal (Fig. 6B, arrowheads), suggesting that the increased ﬂuorescence signal is
caused by an accumulation of membrane material (44, 50, 64). Formation of this extra
membrane material can be caused by overactivation of fatty acid synthesis (65).
However, when either fatty acid synthesis or protein synthesis was blocked with
triclosan or chloramphenicol, respectively, bright membrane patches were still ob-
served upon peptide treatment (Fig. S3D). Alternatively, these membrane accumula-
tions can be caused by plasmolysis due to a loss of turgor pressure and cell shrinkage,
as shown by plunging cells in a sucrose solution (Fig. 6B, bottom panel) (66). To conﬁrm
that tyrocidines A and C cause cell shrinkage, we performed a time-lapse experiment
using cells stained with the membrane dye FM5-95. As shown in Fig. 6C, membrane
patches are formed within minutes, rapidly followed by reduction of the GFP signal in
their immediate proximity and cell shrinkage. Thus, tyrocidines induce large ﬂuorescent
membrane invaginations (patches) by causing a loss of turgor and subsequent cell
shrinkage.
Impact on membrane ﬂuidity. No signs of plasmolysis were observed with gram-
icidin S (Fig. 6B), in line with the fact that this antibiotic does not cause rapid cell lysis
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at inhibitory concentrations (Fig. 1D). However, gramicidin S also caused highly ﬂuo-
rescent membrane patches. Irregular membrane staining of ﬂuorescent membrane
dyes has been observed before when cells were treated with the membrane antibiotic
daptomycin and the proton ionophore CCCP, and the irregularly stained areas were
identiﬁed as highly ﬂuid membrane domains, which increase the ﬂuorescence of
membrane dyes and can also accommodate more dye (50, 64). To examine whether
these bright ﬂuorescent membrane patches are ﬂuid lipid domains, we used the
membrane dye DiIC12, which displays a strong afﬁnity for ﬂuid membranes, including
RIFs, due to its short hydrocarbon tail (50, 67, 68). Indeed, after treatment with
FIG 6 Tyrocidines and gramicidin S cause aberrant membrane staining and plasmolysis. (A) SIM images of B. subtilis 168 stained with MitoTracker green. Note
the unstained membrane areas (arrowheads) and bright lipid accumulations (arrows) in cells treated with tyrocidines A and C. See also Fig. S5A for quantiﬁcation
of membrane patches. (B) Tyrocidines induce membrane invaginations. SIM images of B. subtilis bSS82 expressing cytosolic GFP from the strong ribosomal
PrpsD promoter were stained with Nile red. Sucrose (20%) was used to induce osmotic upshock and used as a control for plasmolysis (bottom panel). (C)
Tyrocidines cause plasmolysis. Time-lapse images of B. subtilis bSS82 cells treated with tyrocidines A and C. Membranes were stained with the nontoxic
membrane dye FM5-95. Arrows indicate membrane patches and corresponding areas with reduced intracellular GFP. Bars, 2 m. Experiments were performed
in early exponential log phase using 1 MIC of the peptides.
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gramicidin S the natural distribution of RIFs was severely disturbed, and the dye
accumulated in one or two large patches per cell (Fig. 7A). The same patches were
observed in cells treated with the tyrocidines (Fig. 7A), and they seem to correspond to
the large membrane invaginations caused by plasmolysis (Fig. 6). Presumably, ﬂuid
membrane domains are more likely to invaginate due to the higher ﬂexibility of ﬂuid
lipids.
To conﬁrm that these large DiIC12-stained membrane patches are indeed more
ﬂuid, we employed laurdan generalized polarization (GP). The ﬂuorescence membrane
dye laurdan shifts its ﬂuorescence spectrum depending on the amount of water
molecules in the bilayer, and laurdan GP can therefore be used as a measure of
phospholipid head group spreading and fatty acid chain ﬂexibility (69, 70). As shown in
Fig. 7B, this assay conﬁrmed that the membrane patches (open arrows) have an
increased ﬂuidity compared to the bulk membrane (ﬁlled arrows). When we quantiﬁed
laurdan GP in the patches and the remaining membrane, it became apparent that not
FIG 7 Effect of tyrocidines and gramicidin S on membrane ﬂuidity. (A) Fluid lipid domain (RIF) staining with DiIC12. (B) Laurdan GP microscopy
indicating local ﬂuidity differences. Filled arrows indicate the cell membrane; open arrows indicate ﬂuid membrane patches. (C) Quantiﬁcation
of membrane ﬂuidity from laurdan microscopy pictures. The minimum GP within the membrane patch and the average GP in the lateral
membrane were measured in individual cells. (D) Changes in overall membrane ﬂuidity measured by laurdan GP in microtiter plate cultures. The
membrane ﬂuidizer benzyl alcohol served as a positive control. The arrow indicates the time point of antibiotic addition. Error bars represent
standard deviations of the mean of three replicate experiments.
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only did the peptides cause ﬂuid membrane patches but this also led to a rigidiﬁcation
of the rest of the membrane (Fig. 7C).
To gain insight into how fast these ﬂuidity changes happen, laurdan GP was
measured spectroscopically in batch culture. We found that there was a rapid (2-min)
reduction of membrane ﬂuidity when the peptide antibiotics were added (Fig. 7D),
indicating that this is a direct effect of peptide-membrane interaction and not a
bacterial adaptation strategy, which would require the induction of speciﬁc enzymes and
thus take more time. In line with our laurdan microscopy data, the overall membrane
rigidiﬁcation was stronger for tyrocidines A and C than for gramicidin S (Fig. 7D), supporting
our notion that the tyrocidines change the physical parameters of the lipid bilayer in a
different way than gramicidin S.
Protein delocalization is independent of MreB. Previous work suggested that RIFs
are formed by MreB polymers, both in B. subtilis and in E. coli (50, 51). All three peptides
caused clustering of MreB (Fig. 5B); therefore, we examined whether these MreB
clusters are responsible for the large DiIC12-stained RIFs that emerge upon addition of
the peptide antibiotics (Fig. 7A). Interestingly, the GFP-MreB clusters did not overlap
DiIC12 clusters, both in the case of gramicidin S and in the case of the tyrocidines
(Fig. 8A). Thus, the peptide antibiotics are able to form artiﬁcial RIFs without the help
of MreB. To conﬁrm this, we tested a triple deletion strain lacking MreB and its
homologues MreBH and Mbl. Indeed, in such mutant cells the addition of gramicidin S
and the tyrocidines still resulted in large DiIC12-stained membrane patches (Fig. S4).
To our surprise, untreated MreB triple mutant cells also showed some small RIFs
(Fig. S4). This is in disagreement with what we have reported previously (50). An
in-depth analysis revealed that DiIC12-stained RIFs become visible only during loga-
rithmic growth and disappear when cells enter the stationary phase of growth, despite
the fact that MreB is still present in the stationary phase (Fig. S4 to S6 and Text S1). This
growth-phase-dependent occurrence of RIFs explained the differences from our previ-
ous ﬁnding. Based on this and previous studies, we propose that MreB is not involved
in establishing RIFs but rather helps to organize them along the cell axis.
Peptides induce ﬂuid lipid domains by stabilizing the liquid crystalline phase.
The previous results suggested that both tyrocidines and gramicidin S induce ﬂuid lipid
domains independently from the MreB cytoskeleton. To conﬁrm that the observed
ﬂuidity changes are a direct cause of peptide-lipid interaction, we tested whether the
peptides inﬂuence phase separation behavior of model lipid membranes using 31P
solid-state nuclear magnetic resonance (NMR). As before, we used 3:1 POPG-POPE
model membranes to mimic Gram-positive bacterial cell membranes. To exclude the
possibility that the observed effects correspond to head group demixing rather than
transition from liquid crystalline to gel phase, we additionally tested pure POPE bilayers.
All three peptides stabilized the liquid crystalline (ﬂuid) phase in both model mem-
brane systems (Fig. S7). For the tyrocidines, similar effects have been described before
in model membranes made of dielaidoylphosphatidylethanolamine (DEPE) (26), and
gramicidin S has been shown to have a preference for more-ﬂuid membranes (32). The
NMR data indicate that the generation of ﬂuid lipid domains is a direct cause of
peptide-lipid interaction and suggest a model in which the peptides preferentially
insert into ﬂuid lipid domains like RIFs and increase their local ﬂuidity. The DiIC12 and
laurdan data suggest that these domains also attract more ﬂexible (ﬂuidizing) lipid
species, further increasing local ﬂuidization.
Membrane proteins localize to ﬂuid domains. The relatively bulky membrane-
targeting domains of most peripheral membrane proteins need a certain ﬂexibility of
the lipid bilayer for their binding and insertion into the membrane (71). Similarly, the
hydrophobic surface area of transmembrane proteins causes an inherent preference of
these proteins for areas of a particular membrane thickness and ﬂuidity (72). It is
therefore likely that the segregation of lipids into ﬂuid and rigid (membrane) domains
by the tyrocidines and gramicidin S (Fig. 7B) is responsible for the observed delocal-
ization of membrane proteins (Fig. 5). To investigate this, we examined the localization
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of MraY (transmembrane) and AtpA (peripheral subunit of a transmembrane complex)
in relation to ﬂuid lipid domains stained with DiIC12. MraY clearly overlapped DiIC12
clusters caused by the tyrocidines and gramicidin S, suggesting that this protein
preferentially partitions from the rigidiﬁed membrane regions into ﬂuid membrane
patches (Fig. 8B). AtpA has been used as a reporter for cell membrane invagination (44,
50), and it does not accumulate in ﬂuid lipid domains caused by antibiotics (50) (also
MP196, Fig. 8B). In line with membrane invaginations due to plasmolysis caused by the
tyrocidines but not by gramicidin S (Fig. 6), AtpA showed a substantial overlap with the
tyrocidine-induced DiIC12 clusters but not with clusters induced by gramicidin S
(Fig. 8C).
FIG 8 Overlap of GFP-tagged proteins with ﬂuid membrane domains. (A to C) Colocalization of MreB (A), MraY (B), and AtpA (C) with DiIC12 was
tested after a 10-min treatment with tyrocidine A, tyrocidine C, and gramicidin S. Open arrows indicate ﬂuid membrane patches induced by the
peptides. Closed arrows indicate membrane areas from which both DiIC12 and AtpA are excluded. (D) Effects of the unrelated antimicrobial
peptides daptomycin and MP196. Cells were treated with 1 g/ml daptomycin (in LB supplemented with 1.25 mM CaCl2) or 10 g/ml MP196. B.
subtilis strains were grown in LB supplemented with appropriate inducer concentrations (Table S1) and treated with peptides in early exponential
growth phase for 10 min. Bar, 2 m.
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To compare the effects of the tyrocidines and gramicidin S with those of other
membrane-targeting peptides, we performed the same costaining experiment with
two well-studied antimicrobial peptides, the lipopeptide daptomycin, which selectively
inserts into RIFs and tightly aggregates them into rigid clusters (44), and the small
cationic peptide MP196, which disturbs membrane architecture and depolarizes the
membrane by inhibiting the respiratory chain (39). In line with an earlier study (44),
daptomycin only slightly affected the localization of MreB and had no effect on MraY
and AtpA localization (Fig. 8B). On the other hand, MP196 caused MreB clusters that
overlapped aggregated RIFs, which is typical for depolarizing compounds (50). MraY
also accumulated in the DiIC12-stained membrane patches, whereas AtpA localization
was unaffected. These effects are quite different from what was observed with the
tyrocidines and gramicidin S, indicating that these old peptide antibiotics disrupt the
bacterial cell membrane by thus-far unique mechanisms.
Inﬂuence on the chromosome. Although the bacterial cell membrane is consid-
ered the key target of both the tyrocidines and gramicidin S, in vitro experiments have
shown that these antibiotics also interact with DNA (40–43). However, it has never been
shown whether this DNA-binding activity plays a role in vivo. To investigate this, we
stained the bacterial chromosome with the DNA-binding dye 4=,6-diamidino-2-
phenylindole (DAPI). Cells treated with tyrocidines A and C showed a clear condensa-
tion of the nucleoid (Fig. 9A). As a control, we treated cells with CCCP but did not
observe any nucleoid condensation, indicating that this is not a mere effect of mem-
brane depolarization (Fig. 9A). Since nucleoid condensation occurred rapidly (2 min)
and coincided with shrinking of the cells, it is possible that loss of turgor pressure plays
a role in tyrocidine-induced nucleoid condensation. In fact, an osmotic upshock can
lead to plasmolysis, nucleoid compaction, and dissociation of RNA polymerase from the
FIG 9 Inﬂuence of tyrocidines and gramicidin S on the bacterial chromosome. (A) Tyrocidines cause condensation of the nucleoid within
2 min. CCCP was included as a control for depolarization. DNA was stained with DAPI. Strain, B. subtilis 168. (B) Localization of
DNA-associated proteins (see main text for details). B. subtilis strains were grown in LB with appropriate inducer concentrations (see
Table S1) and treated with peptides in early exponential growth phase for 10 min. The ribosomal subunit protein RpsB was chosen as
control for a cytosolic protein not associated with the nucleoid. Bars, 2 m.
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DNA (73). Therefore, we examined the localization of RNA polymerase by tagging its
subunit RpoC with GFP. As shown in Fig. 8B, RNA polymerase remained attached to the
nucleoid but seemed to cluster. To test whether the peptides inﬂuence DNA replication,
we examined the localization of the DNA replication regulator ParB (Spo0J) (74, 75) and
the DNA polymerase subunit DnaN. The ribosome subunit RpsB was included as a
cytosolic control protein. Both tyrocidines caused a complete detachment of ParB from
the origin of replication (Fig. 9B). DnaN remained attached to the chromosome but
exhibited some clustering toward the center of the cells after treatment with tyrocid-
ines A and C (Fig. 9B). The same effect is seen with the gyrase inhibitor ciproﬂoxacin
(60), which causes arrest of the replication fork (76). RpsB, which is not associated with
DNA, was not affected by the peptides. To examine whether the peptides cause DNA
damage, we looked at the localization of RecA. Upon DNA damage, this repair protein
forms large nucleoprotein ﬁlaments (77, 78). As shown in Fig. 8B, RecA formed clear foci
after treatment with tyrocidines A and C. In contrast to the tyrocidines, gramicidin S had
no effect on the localization of any of these proteins. These results indicate that the
tyrocidines also target the bacterial DNA, resulting in inhibition of DNA replication and
DNA damage, whereas gramicidin S does not show any DNA-targeting activity in vivo.
Activity against persister cells. Antibiotic tolerance caused by nongrowing per-
sister cells is an important problem in antibacterial therapy as it leads to chronic and
recurrent bacterial infections (79). Membrane-active compounds have been suggested
as treatment options for such persistent infections (80). Since the tyrocidines and
gramicidin S affect multiple cellular processes, including the cell membrane, we tested
the potential of the peptides to kill nongrowing overnight cultures of B. subtilis and S.
aureus that have been used as simple model systems for persister cells (81, 82). As
shown in Fig. 9A, ampicillin and chloramphenicol were highly active against growing B.
subtilis and S. aureus cultures (Fig. 10A). However, overnight cultures were completely
resistant to 9-h treatment with these antibiotics. In contrast, both the tyrocidines and
gramicidin S were highly efﬁcient in killing nongrowing B. subtilis cells (Fig. 10B). A 9-h
incubation with the tyrocidines killed 90% to 99% of nongrowing S. aureus cells,
whereas gramicidin S achieved a CFU reduction of as much as 5 log units (Fig. 10C),
underlining the clinical potential of the peptides.
DISCUSSION
There is a considerable amount of literature on how antimicrobial peptides interact
with model membrane systems (26, 30, 31, 83, 84). However, only very limited infor-
mation is available on how these antibiotics affect bacterial cells in vivo, even for
tyrocidines and gramicidin S, the oldest natural peptide antibiotics in clinical use (2, 3).
Here, we report the ﬁrst comprehensive in vivo mode of action study of these cyclic
-sheet decapeptides and show that they act very differently, despite sharing 50%
sequence homology.
Both the tyrocidines and gramicidin S affect membrane ﬂuidity, membrane poten-
tial, and the localization of essential peripheral membrane proteins. However, the effect
of tyrocidines on the cell membrane is much more severe, leading to membrane pores,
phase separation into ﬂuid membrane foci and rigid gel-phase domains, membrane
invaginations, and delocalized transmembrane proteins.
We noticed only subtle differences between tyrocidines A and C. Tyrocidine C
preferentially causes ion channels with higher current amplitudes, while tyrocidine A
showed a broader distribution of current amplitudes in model membranes. Tyrocidine
C possesses bulkier amino acid side chains (Trp-D-Trp) than tyrocidine A (Phe-D-Phe) at
the variable aromatic dipeptide unit (Fig. 1A and B), which could indicate a stronger
spreading of membrane lipids and therefore higher pore-forming capacity. In line with
this, tyrocidine C was more active against B. subtilis and S. aureus than tyrocidine A,
suggesting that pore formation is an important part of the mechanism of action of
these peptides.
Gramicidin S appeared to work very differently than the tyrocidines. Gramicidin S
does not form discrete membrane pores, affects only the localization of peripheral
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membrane proteins, and does not form overt gel-phase domains. However, like the
tyrocidines, it does form large ﬂuid membrane domains independent of MreB. Early in
vitro studies have proposed lipid phase separation for the mechanism of gramicidin S
(90), which is supported by our NMR results. The microscopic images of DiIC12-stained
ﬂuid domains show for the ﬁrst time that lipid demixing does indeed occur in vivo.
FIG 10 Activity against growing and nongrowing cultures of B. subtilis 168 and S. aureus 8325. (A) MIC(s)
against B. subtilis, the model organism used in this study, and the pathogenic Gram-positive bacterium
S. aureus. MICs for B. subtilis were additionally determined in a test tube assay to exactly match the
conditions for mode-of-action experiments. (B) Log10 CFU reduction of nongrowing B. subtilis and S.
aureus cultures treated with ampicillin and chloramphenicol. (C) Log10 CFU reduction of nongrowing B.
subtilis and S. aureus cultures (stationary overnight cultures).
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It is curious that gramicidin S, which shares half of its sequence with the tyrocidines
(Fig. 1A to C), has such different effects on the cell membrane. Both tyrocidines and
gramicidin S insert superﬁcially into the membrane, namely, at the interface between
phospholipid head groups and fatty acid chains (32, 91, 92). However, these studies
have been performed in different membrane systems, and at least for gramicidin S, it
is known that afﬁnity and penetration depth depend on both lipid head group
composition and membrane ﬂuidity (32). A systematic comparative study will be
needed to reach a ﬁnal conclusion on the differences in membrane interaction between
these peptide antibiotics. Tyrocidines possess four aromatic residues, while gramicidin
S has only two phenylalanine residues. Furthermore, both tyrocidines A and C form
dimers, while dimerization of gramicidin S is deemed unlikely (91, 93). Therefore, one
might speculate that the bulkier side chains of tyrocidines together with dimerization
lead to stronger lipid spreading and, thus, more pronounced membrane effects than
those of gramicidin S.
Fluid membrane domains are induced by all three peptides both in vivo and in vitro,
showing that this kind of phase separation is not underlying pore formation. Instead,
the formation of gel-phase domains and rigidiﬁcation of the bulk membrane occurred
only in cells treated with the pore-forming peptides tyrocidines A and C. The interface
between membrane domains of considerably different ﬂuidity constitutes a weak spot
in the lipid bilayer and is assumed to facilitate ion leakage (85–89). It is likely that the
interface between highly ﬂuid membrane domains and the rigidiﬁed rest membrane
plays a crucial role in the pore-forming ability of the tyrocidines. However, the exact
mechanism of how the tyrocidines achieve membrane rigidiﬁcation and induce gel-
phase domains cannot be determined in this study.
Another important difference between gramicidin S and the tyrocidines is that the
latter cause DNA damage and interfere with DNA-binding proteins. Tyrocidines contain
two more aromatic amino acids than gramicidin S (Fig. 1A), and it has been shown that
aromatic amino acids can intercalate between the N bases in DNA and interfere with
N-base stacking interactions (94). Apparently, while gramicidin S is also able to bind to
DNA (42) in vitro, this is not reﬂected in the in vivo situation.
So far, most antimicrobial peptides are studied in model membrane systems,
resulting in pore formation being the prevailing mechanistic model for these com-
pounds. However, biophysical studies are done with artiﬁcial membrane systems,
conditions that fail to capture the complexity of biological membranes (44, 95). Our in
vivo study sheds new light on the antibacterial mechanism of these pioneering cyclic
-sheet decapeptide antibiotics, revealing a much more multifaceted and complex
mechanism than previously thought. This may explain why both the tyrocidines and
gramicidin S are still so effective after decades of clinical application and why there is
virtually no resistance to them. Interestingly, the effect of gramicidin S on the bacterial
membrane is less severe than that of the tyrocidines, yet gramicidin S is equally as or
even more efﬁcient in killing both growing and nongrowing bacteria. The latter is
interesting, since persistent and recurrent bacterial infections caused by nongrowing
persister cells impose great difﬁculties in the clinic (79). While classical antibiotics such
as chloramphenicol and ampicillin target biosynthetic processes, they fail to kill non-
growing cells. Therefore, membrane-active antibiotics have been proposed as treat-
ment options for persistent infections (18, 79, 80). Our data on the tyrocidines and
gramicidin S corroborate this. Since the tyrocidines impair the function of the bacterial
membrane at both biosynthetic (cell division, cell wall, membrane, and ATP synthesis) and
structural (ﬂotillin, membrane phase separation, and membrane pores) levels, and addi-
tionally affect DNA packing, cells have little possibility to recover from exposure to these
peptide antibiotics. Gramicidin S has less effect on the cell membrane and no effect on the
bacterial nucleoid, yet it is only slightly less efﬁcient against stationary B. subtilis and much
more efﬁcient against stationary S. aureus cells. S. aureus has a considerably different lipid
composition than B. subtilis in terms of both head groups and fatty acids (96, 97), which
might explain these differences. Our results underline that classic pore formation is not
necessarily a requirement for efﬁcient killing of bacteria.
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MATERIALS AND METHODS
Details on antibiotics, bacterial strains, and experimental procedures can be found in Text S2 in the
supplemental material. A list of B. subtilis strains used in this study is displayed in Table S1. All strains
were grown at 30°C under steady agitation in Luria-Bertani broth (LB). MICs were determined in a
standard serial dilution assay. Growth experiments were carried out in 96-well format in a temperature-
controlled BioTek Synergy MX plate reader under continuous shaking. All mode-of-action assays were
performed with log-phase B. subtilis cells at an OD at 600 nm (OD600) of 0.3 at 30°C under steady
agitation. Unless otherwise noted, cells were treated with 1MIC of the respective antibiotics for 10 min.
Fluorescence microscopy and staining of cells with ﬂuorescent dyes were carried out as described
previously (44, 60, 98). Electron microscopy was performed using a recently described ﬂat embedding
technique (60). The membrane potential was measured with DiSC(3)5 as described by Te Winkel et al.
(98). Propidium iodide inﬂux and laurdan spectroscopic assays were essentially performed as described
by Müller et al. (44). Electrophysiological and NMR measurements were performed in 3:1 POPG-POPE or
pure POPE, respectively, as described in Text S2. Time-lapse microscopy and SIM were essentially
performed as described by Saeloh et al. (60). Activity against stationary-phase cells was determined using
overnight cultures of B. subtilis and S. aureus. Antibiotic concentrations were adjusted to the higher cell
count, and cells were incubated with antibiotics for 9 h prior to CFU determination.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/mBio
.00802-18.
TEXT S1, DOCX ﬁle, 0.02 MB.
TEXT S2, DOCX ﬁle, 0.03 MB.
FIG S1, TIF ﬁle, 0.2 MB.
FIG S2, TIF ﬁle, 0.5 MB.
FIG S3, TIF ﬁle, 1.6 MB.
FIG S4, TIF ﬁle, 0.5 MB.
FIG S5, TIF ﬁle, 1.1 MB.
FIG S6, TIF ﬁle, 0.1 MB.
FIG S7, TIF ﬁle, 0.7 MB.
TABLE S1, DOCX ﬁle, 0.02 MB.
ACKNOWLEDGMENTS
We thank Marietjie Stander (LCMS Central Analytical Facility, Stellenbosch Univer-
sity) for assistance with high-resolution electrospray mass spectrometry analysis, Jan
R. T. van Weering and Marien P. Dekker (Center for Neurogenomics and Cognitive
Research, VU University Amsterdam) for excellent technical support with electron
microscopy, and Nils Metzler-Nolte (Ruhr University Bochum) for supplying MP196. E.Z.
is grateful to Juan Del Rio Martinez for the excellent technical assistance with single-
channel analysis.
Electron microscopy was performed at the VU/VUmc electron microscopy facility,
supported by the Netherlands Organization for Scientiﬁc Research (NWO, middelgroot
91111009). This work was funded by an NWO Vici grant (STW-Vici 12128 to L.W.H.), the
BIOPEP Peptide Fund (to M.R.), and a Protea SA-France exchange grant (to M.R. and
B.B.). M.W. was supported by a postdoc stipend of the Amsterdam Infection and
Immunity Institute.
M.W. designed the study, planned and performed in vivo experiments, analyzed
data, and wrote the paper. M.R. and B.B. planned experiments, analyzed data, and
cowrote the paper. T.S. assisted with in vivo experiments. J.A.V., W.E.L., and W.V.R.
performed experiments and analyzed data pertaining to the peptide preparation,
chemical analysis, and model membrane studies. C.H.M.A., E.Z., and J.C.B. planned and
performed experiments and analyzed data pertaining to the biophysical analysis of the
peptides in model membranes. L.W.H. codesigned the study and edited the paper.
REFERENCES
1. Tang X-J, Thibault P, Boyd RK. 1992. Characterisation of the tyrocidine
and gramicidin fractions of the tyrothricin complex from Bacillus brevis
using liquid chromatography and mass spectrometry. Int J Mass Spec-
trom Ion Process 122:153–179. https://doi.org/10.1016/0168-1176(92)
87015-7.
2. Cooper JE. 2007. A brief romance with magic bullets: René Dubos at the
dawn of the antibiotic era, p 44–62. In Ward JW, Warren C (ed), Silent
victories: the history and practice of public health in twentieth century
America. Oxford University Press, New York, NY.
3. Gall YM, Konashev MB. 2001. The discovery of gramicidin S: the intel-
Modes of Action of Tyrocidines and Gramicidin S ®
September/October 2018 Volume 9 Issue 5 e00802-18 mbio.asm.org 17
 o
n
 M
ay 9, 2019 by guest
http://m
bio.asm
.org/
D
ow
nloaded from
 
lectual transformation of G.F. Gause from biologist to researcher of
antibiotics and on its meaning for the fate of Russian genetics. Hist
Philos Life Sci 23:137–150.
4. Hancock RE, Chapple DS. 1999. Peptide antibiotics. Antimicrob Agents
Chemother 43:1317–1323.
5. Henderson J. 1946. The status of tyrothricin as an antibiotic agent for
topical application. J Am Pharm Assoc Am Pharm Assoc 35:141–147.
https://doi.org/10.1002/jps.3030350503.
6. Goldman L, Feldman MD, Altemeier WA. 1948. Contact dermatitis from
topical tyrothricin and associated with polyvalent hypersensitivity to
various antibiotics; report of a case. J Invest Dermatol 11:243. https://
doi.org/10.1038/jid.1948.92.
7. Wigger-Alberti W, Stauss-Grabo M, Grigo K, Atiye S, Williams R, Korting
HC. 2013. Efﬁcacy of a tyrothricin-containing wound gel in an abrasive
wound model for superﬁcial wounds. Skin Pharmacol Physiol 26:52–56.
https://doi.org/10.1159/000343907.
8. Dimick KP. 1951. The hemolytic action of gramicidin and tyrocidin. Proc
Soc Exp Biol Med 78:782–784. https://doi.org/10.3181/00379727-78
-19217.
9. Lang C, Staiger C. 2016. Tyrothricin—an underrated agent for the treat-
ment of bacterial skin infections and superﬁcial wounds? Pharmazie
71:299–305.
10. Krylov Y. 1993. Compendium of medicinal products of Russia. Inpharm-
chem Press, Moscow, Russia.
11. Spathelf BM, Rautenbach M. 2009. Anti-listerial activity and structure-
activity relationships of the six major tyrocidines, cyclic decapeptides
from Bacillus aneurinolyticus. Bioorg Med Chem 17:5541–5548. https://
doi.org/10.1016/j.bmc.2009.06.029.
12. Leussa AN-N, Rautenbach M. 2014. Detailed SAR and PCA of the tyroci-
dines and analogues towards leucocin A-sensitive and leucocin
A-resistant Listeria monocytogenes. Chem Biol Drug Des 84:543–557.
https://doi.org/10.1111/cbdd.12344.
13. Troskie AM, de Beer A, Vosloo JA, Jacobs K, Rautenbach M. 2014.
Inhibition of agronomically relevant fungal phytopathogens by tyrocid-
ines, cyclic antimicrobial peptides isolated from Bacillus aneurinolyticus.
Microbiology 160:2089–2101. https://doi.org/10.1099/mic.0.078840-0.
14. Troskie AM, Rautenbach M, Delattin N, Vosloo JA, Dathe M, Cammue
BPA, Thevissen K. 2014. Synergistic activity of the tyrocidines, antimicro-
bial cyclodecapeptides from Bacillus aneurinolyticus, with amphotericin
B and caspofungin against Candida albicans bioﬁlms. Antimicrob Agents
Chemother 58:3697–3707. https://doi.org/10.1128/AAC.02381-14.
15. Rautenbach M, Vlok NM, Stander M, Hoppe HC. 2007. Inhibition of
malaria parasite blood stages by tyrocidines, membrane-active cyclic
peptide antibiotics from Bacillus brevis. Biochim Biophys Acta 1768:
1488–1497. https://doi.org/10.1016/j.bbamem.2007.01.015.
16. Kondejewski LH, Farmer SW, Wishart DS, Kay CM, Hancock RE, Hodges
RS. 1996. Modulation of structure and antibacterial and hemolytic ac-
tivity by ring size in cyclic gramicidin S analogs. J Biol Chem 271:
25261–25268. https://doi.org/10.1074/jbc.271.41.25261.
17. Stauss-Grabo M, Atiye S, Le T, Kretschmar M. 2014. Decade-long use of
the antimicrobial peptide combination tyrothricin does not pose a major
risk of acquired resistance with gram-positive bacteria and Candida spp.
Pharmazie 69:838–841.
18. Berditsch M, Lux H, Babii O, Afonin S, Ulrich AS. 2016. Therapeutic
potential of gramicidin S in the treatment of root canal infections.
Pharmaceuticals 9:56. https://doi.org/10.3390/ph9030056.
19. Marques MA, Citron DM, Wang CC. 2007. Development of tyrocidine A
analogues with improved antibacterial activity. Bioorg Med Chem 15:
6667–6677. https://doi.org/10.1016/j.bmc.2007.08.007.
20. Swierstra J, Kapoerchan V, Knijnenburg A, van Belkum A, Overhand M.
2016. Structure, toxicity and antibiotic activity of gramicidin S and
derivatives. Eur J Clin Microbiol Infect Dis 35:763–769. https://doi.org/
10.1007/s10096-016-2595-y.
21. Knijnenburg AD, Kapoerchan VV, Grotenbreg GM, Spalburg E, de Neel-
ing AJ, Mars-Groenendijk RH, Noort D, Otero JM, Llamas-Saiz AL, van
Raaij MJ, Ravensbergen B, Nibbering PH, van der Marel GA, Overkleeft
HS, Overhand M. 2011. Synthesis and evaluation of strand and turn
modiﬁed ring-extended gramicidin S derivatives. Bioorg Med Chem
19:3402–3409. https://doi.org/10.1016/j.bmc.2011.04.031.
22. Pal S, Singh G, Singh S, Tripathi JK, Ghosh JK, Sinha S, Ampapathi RS,
Chakraborty TK. 2015. Tetrahydrofuran amino acid-containing gramici-
din S analogues with improved biological proﬁles. Org Biomol Chem
13:6789–6802. https://doi.org/10.1039/C5OB00622H.
23. Tamaki M, Harada T, Fujinuma K, Takanashi K, Shindo M, Kimura M,
Uchida Y. 2012. Polycationic gramicidin S analogues with both high
antibiotic activity and very low hemolytic activity. Chem Pharm Bull
60:1134–1138. https://doi.org/10.1248/cpb.c12-00290.
24. Tamaki M, Takanashi K, Harada T, Fujinuma K, Shindo M, Kimura M,
Uchida Y. 2011. Novel cycloundecapeptides related to gramicidin S with
both high antibiotic activity and low hemolytic activity. Chem Pharm
Bull 59:1481–1484. https://doi.org/10.1248/cpb.59.1481.
25. Kamysz E, Mickiewicz B, Kamysz W, Bielin´ska S, Rodziewicz-Motowidło S,
Ciarkowski J. 2011. Synthesis, biological activity and solution structure of
new analogues of the antimicrobial gramicidin S. J Pept Sci 17:211–217.
https://doi.org/10.1002/psc.1314.
26. Aranda FJ, de Kruijff B. 1988. Interrelationships between tyrocidine and
gramicidin A’ in their interaction with phospholipids in model mem-
branes. Biochim Biophys Acta 937:195–203. https://doi.org/10.1016/
0005-2736(88)90241-6.
27. Rautenbach M, Troskie AM, Vosloo JA, Dathe ME. 2016. Antifungal
membranolytic activity of the tyrocidines against ﬁlamentous plant
fungi. Biochimie 130:122–131. https://doi.org/10.1016/j.biochi.2016.06
.008.
28. Dubos R, Hotchkiss R, Coburn A. 1942. The effect of gramicidin and
tyrocidine bacterial metabolism. J Biol Chem 146:421–426.
29. Seddon B, McVittie J. 1974. The effect of inhibitors on the electron-
transport chain of Bacillus brevis. Evidence for branching of the NADH
oxidase respiratory chain. J Gen Microbiol 84:386–390. https://doi.org/
10.1099/00221287-84-2-386.
30. Jelokhani-Niaraki M, Hodges RS, Meissner JE, Hassenstein UE, Wheaton L.
2008. Interaction of gramicidin S and its aromatic amino-acid analog
with phospholipid membranes. Biophys J 95:3306–3321. https://doi.org/
10.1529/biophysj.108.137471.
31. Ashrafuzzaman M, Andersen OS, McElhaney RN. 2008. The antimicrobial
peptide gramicidin S permeabilizes phospholipid bilayer membranes
without forming discrete ion channels. Biochim Biophys Acta 1778:
2814–2822. https://doi.org/10.1016/j.bbamem.2008.08.017.
32. Prenner EJ, Lewis RNAH, McElhaney RN. 1999. The interaction of the
antimicrobial peptide gramicidin S with lipid bilayer model and biolog-
ical membranes. Biochim Biophys Acta 1462:201–221. https://doi.org/10
.1016/S0005-2736(99)00207-2.
33. Katsu T, Kuroko M, Morikawa T, Sanchika K, Fujita Y, Yamamura H, Uda
M. 1989. Mechanism of membrane damage induced by the amphipathic
peptides gramicidin S and melittin. Biochim Biophys Acta 983:135–141.
https://doi.org/10.1016/0005-2736(89)90226-5.
34. Katsu T, Ninomiya C, Kuroko M, Kobayashi H, Hirota T, Fujita Y. 1988.
Action mechanism of amphipathic peptides gramicidin S and melittin on
erythrocyte membrane. Biochim Biophys Acta 939:57–63. https://doi
.org/10.1016/0005-2736(88)90047-8.
35. Katsu T, Imamura T, Komagoe K, Masuda K, Mizushima T. 2007. Simul-
taneous measurements of K and calcein release from liposomes and
the determination of pore size formed in a membrane. Anal Sci 23:
517–522. https://doi.org/10.2116/analsci.23.517.
36. Afonin S, Durr UHN, Wadhwani P, Salgado J, Ulrich AS. 2008. Solid state
NMR structure analysis of the antimicrobial peptide gramicidin S in lipid
membranes: concentration-dependent re-alignment and self-assembly
as a beta-barrel. Top Curr Chem 273:139–154. https://doi.org/10.1007/
128_2007_20.
37. Wenzel M, Kohl B, Münch D, Raatschen N, Albada HB, Hamoen L,
Metzler-Nolte N, Sahl HG, Bandow JE. 2012. Proteomic response of
Bacillus subtilis to lantibiotics reﬂects differences in interaction with the
cytoplasmic membrane. Antimicrob Agents Chemother 56:5749–5757.
https://doi.org/10.1128/AAC.01380-12.
38. Vostroknutova GN, Bulgakova VG, Udalova TP, Sepetov NF, Sibel’dina LA.
1981. Localization of gramicidin S on the cytoplasmic membrane of
Bacillus brevis and its effect on the activity of membrane enzymes.
Biokhimiia 46:657–666.
39. Wenzel M, Chiriac AI, Otto A, Zweytick D, May C, Schumacher C, Gust R,
Albada HB, Penkova M, Krämer U, Erdmann R, Metzler-Nolte N, Straus SK,
Bremer E, Becher D, Brötz-Oesterhelt H, Sahl H-G, Bandow JE. 2014. Small
cationic antimicrobial peptides delocalize peripheral membrane pro-
teins. Proc Natl Acad Sci U S A 111:E1409–E1418. https://doi.org/10
.1073/pnas.1319900111.
40. Krauss EM, Chan SI. 1984. Complexation and phase transfer of nucleic
acids by gramicidin S. Biochemistry 23:73–77. https://doi.org/10.1021/
bi00296a012.
41. Bohg A, Ristow H. 1987. Tyrocidine-induced modulation of the DNA
Wenzel et al. ®
September/October 2018 Volume 9 Issue 5 e00802-18 mbio.asm.org 18
 o
n
 M
ay 9, 2019 by guest
http://m
bio.asm
.org/
D
ow
nloaded from
 
conformation in Bacillus brevis. Eur J Biochem 170:253–258. https://doi
.org/10.1111/j.1432-1033.1987.tb13693.x.
42. Hansen J, Pschorn W, Ristow H. 1982. Functions of the peptide antibi-
otics tyrocidine and gramicidin. Induction of conformational and struc-
tural changes of superhelical DNA. Eur J Biochem 126:279–284. https://
doi.org/10.1111/j.1432-1033.1982.tb06776.x.
43. Ristow H, Schazschneider B, Vater J, Kleinkauf H. 1975. Some character-
istics of the DNA-tyrocidine complex and a possible mechanism of the
gramicidin action. Biochim Biophys Acta 414:1–8. https://doi.org/10
.1016/0005-2787(75)90120-3.
44. Müller A, Wenzel M, Strahl H, Grein F, Saaki TNV, Kohl B, Siersma T,
Bandow JE, Sahl H-G, Schneider T, Hamoen LW. 2016. Daptomycin
inhibits bacterial cell envelope synthesis by interfering with ﬂuid mem-
brane microdomains. Proc Natl Acad Sci U S A 113:E7077–E7086. https://
doi.org/10.1073/pnas.1611173113.
45. Schneider T, Kruse T, Wimmer R, Wiedemann I, Sass V, Pag U, Jansen A,
Nielsen AK, Mygind PH, Raventós DS, Neve S, Ravn B, Bonvin AMJJ, De
Maria L, Andersen AS, Gammelgaard LK, Sahl H-G, Kristensen H-H. 2010.
Plectasin, a fungal defensin, targets the bacterial cell wall precursor lipid
II. Science 328:1168–1172. https://doi.org/10.1126/science.1185723.
46. Wenzel M, Patra M, Senges CHR, Ott I, Stepanek JJ, Pinto A, Prochnow P,
Vuong C, Langklotz S, Metzler-Nolte N, Bandow JE. 2013. Analysis of the
mechanism of action of potent antibacterial hetero-tri-organometallic
compounds: a structurally new class of antibiotics. ACS Chem Biol
8:1442–1450. https://doi.org/10.1021/cb4000844.
47. Strahl H, Hamoen LW. 2010. Membrane potential is important for bac-
terial cell division. Proc Natl Acad Sci U S A 107:12281–12286. https://
doi.org/10.1073/pnas.1005485107.
48. Jones LJ, Carballido-López R, Errington J. 2001. Control of cell shape in
bacteria: helical, actin-like ﬁlaments in Bacillus subtilis. Cell 104:913–922.
https://doi.org/10.1016/S0092-8674(01)00287-2.
49. Daniel RA, Errington J. 2003. Control of cell morphogenesis in bacteria:
two distinct ways to make a rod-shaped cell. Cell 113:767–776. https://
doi.org/10.1016/S0092-8674(03)00421-5.
50. Strahl H, Burmann F, Hamoen LW. 2014. The actin homologue MreB
organizes the bacterial cell membrane. Nat Commun 5:3442. https://doi
.org/10.1038/ncomms4442.
51. Oswald F, Varadarajan A, Lill H, Peterman EJG, Bollen YJM. 2016. MreB-
dependent organization of the E. coli cytoplasmic membrane controls
membrane protein diffusion. Biophys J 110:1139–1149. https://doi.org/
10.1016/j.bpj.2016.01.010.
52. Bramkamp M, Lopez D. 2015. Exploring the existence of lipid rafts in
bacteria. Microbiol Mol Biol Rev 79:81–100. https://doi.org/10.1128/
MMBR.00036-14.
53. Lopez D, Kolter R. 2010. Functional microdomains in bacterial mem-
branes. Genes Dev 24:1893–1902. https://doi.org/10.1101/gad.1945010.
54. Bach JN, Bramkamp M. 2013. Flotillins functionally organize the bacterial
membrane. Mol Microbiol 88:1205–1217. https://doi.org/10.1111/mmi
.12252.
55. Reference deleted.
56. Schneider J, Klein T, Mielich-Suss B, Koch G, Franke C, Kuipers OP, Kovacs
AT, Sauer M, Lopez D. 2015. Spatio-temporal remodeling of functional
membrane microdomains organizes the signaling networks of a bacte-
rium. PLoS Genet 11:e1005140. https://doi.org/10.1371/journal.pgen
.1005140.
57. Yepes A, Schneider J, Mielich B, Koch G, García-Betancur J-C, Ramamurthi
KS, Vlamakis H, López D. 2012. The bioﬁlm formation defect of a Bacillus
subtilis ﬂotillin-defective mutant involves the protease FtsH. Mol Microbiol
86:457–471. https://doi.org/10.1111/j.1365-2958.2012.08205.x.
58. Dempwolff F, Moller HM, Graumann PL. 2012. Synthetic motility and cell
shape defects associated with deletions of ﬂotillin/reggie paralogs in
Bacillus subtilis and interplay of these proteins with NfeD proteins. J
Bacteriol 194:4652–4661. https://doi.org/10.1128/JB.00910-12.
59. Seddon B, Fynn G. 1973. Energetics of growth in a tyrothricin-producing
strain of Bacillus brevis. J Gen Microbiol 74:305–314. https://doi.org/10
.1099/00221287-74-2-305.
60. Saeloh D, Tipmanee V, Jim KK, Dekker MP, Bitter W, Voravuthikunchai SP,
Wenzel M, Hamoen LW. 2018. The novel antibiotic rhodomyrtone traps
membrane proteins in vesicles with increased ﬂuidity. PLoS Pathog
14:e1006876. https://doi.org/10.1371/journal.ppat.1006876.
61. Platt-Aloia KA, Thomson WW. 1985. Freeze-fracture evidence of gel-
phase lipid in membranes of senescing cowpea cotyledons. Planta
163:360–369. https://doi.org/10.1007/BF00395144.
62. Dupuy F, Morero R. 2011. Microcin J25 membrane interaction: selectivity
toward gel phase. Biochim Biophys Acta 1808:1764–1771. https://doi
.org/10.1016/j.bbamem.2011.02.018.
63. Rintoul MR, Morero RD, Dupuy FG. 2015. The antimicrobial peptide
microcin J25 stabilizes the gel phase of bacterial model membranes.
Colloids Surf B Biointerfaces 129:183–190. https://doi.org/10.1016/j
.colsurfb.2015.03.048.
64. Kucherak OA, Oncul S, Darwich Z, Yushchenko DA, Arntz Y, Didier P,
Mely Y, Klymchenko AS. 2010. Switchable Nile red-based probe for
cholesterol and lipid order at the outer leaﬂet of biomembranes. J Am
Chem Soc 132:4907–4916. https://doi.org/10.1021/ja100351w.
65. Mercier R, Kawai Y, Errington J. 2013. Excess membrane synthesis drives
a primitive mode of cell proliferation. Cell 152:997–1007. https://doi.org/
10.1016/j.cell.2013.01.043.
66. Weibull C. 1965. Plasmolysis in Bacillus megaterium. J Bacteriol 89:
1151–1154.
67. Baumgart T, Hunt G, Farkas ER, Webb WW, Feigenson GW. 2007. Fluo-
rescence probe partitioning between Lo/Ld phases in lipid membranes.
Biochim Biophys Acta 1768:2182–2194. https://doi.org/10.1016/j.bbamem
.2007.05.012.
68. Zhao J, Wu J, Veatch SL. 2013. Adhesion stabilizes robust lipid hetero-
geneity in supercritical membranes at physiological temperature. Bio-
phys J 104:825–834. https://doi.org/10.1016/j.bpj.2012.12.047.
69. Parasassi T, Gratton E. 1995. Membrane lipid domains and dynamics as
detected by laurdan ﬂuorescence. J Fluoresc 5:59–69. https://doi.org/
10.1007/BF00718783.
70. Andrich MP, Vanderkooi JM. 1976. Temperature dependence of 1,6-
diphenyl-1,3,5-hexatriene ﬂuorescence in phospholipid artiﬁcial mem-
branes. Biochemistry 15:1257–1261. https://doi.org/10.1021/bi00651a013.
71. McMahon HT, Gallop JL. 2005. Membrane curvature and mechanisms of
dynamic cell membrane remodelling. Nature 438:590–596. https://doi
.org/10.1038/nature04396.
72. Lee AG. 2004. How lipids affect the activities of integral membrane
proteins. Biochim Biophys Acta 1666:62–87. https://doi.org/10.1016/j
.bbamem.2004.05.012.
73. Cagliero C, Jin DJ. 2013. Dissociation and re-association of RNA poly-
merase with DNA during osmotic stress response in Escherichia coli.
Nucleic Acids Res 41:315–326. https://doi.org/10.1093/nar/gks988.
74. Kleine Borgmann LAK, Hummel H, Ulbrich MH, Graumann PL. 2013. SMC
condensation centers in Bacillus subtilis are dynamic structures. J Bac-
teriol 195:2136–2145. https://doi.org/10.1128/JB.02097-12.
75. Lin DC, Grossman AD. 1998. Identiﬁcation and characterization of a
bacterial chromosome partitioning site. Cell 92:675–685. https://doi.org/
10.1016/S0092-8674(00)81135-6.
76. Collin F, Karkare S, Maxwell A. 2011. Exploiting bacterial DNA gyrase as
a drug target: current state and perspectives. Appl Microbiol Biotechnol
92:479–497. https://doi.org/10.1007/s00253-011-3557-z.
77. Lenhart JS, Brandes ER, Schroeder JW, Sorenson RJ, Showalter HD,
Simmons LA. 2014. RecO and RecR are necessary for RecA loading in
response to DNA damage and replication fork stress. J Bacteriol 196:
2851–2860. https://doi.org/10.1128/JB.01494-14.
78. Meile J-C, Wu LJ, Ehrlich SD, Errington J, Noirot P. 2006. Systematic
localisation of proteins fused to the green ﬂuorescent protein in Bacillus
subtilis: identiﬁcation of new proteins at the DNA replication factory.
Proteomics 6:2135–2146. https://doi.org/10.1002/pmic.200500512.
79. Lewis K. 2012. Persister cells: molecular mechanisms related to antibiotic
tolerance. Handb Exp Pharmacol 211:121–133. https://doi.org/10.1007/
978-3-642-28951-4_8.
80. Hurdle JG, O’Neill AJ, Chopra I, Lee RE. 2011. Targeting bacterial membrane
function: an underexploited mechanism for treating persistent infections.
Nat Rev Microbiol 9:62–75. https://doi.org/10.1038/nrmicro2474.
81. Orman MA, Brynildsen MP. 2015. Inhibition of stationary phase respira-
tion impairs persister formation in E. coli. Nat Commun 6:7983. https://
doi.org/10.1038/ncomms8983.
82. Volzing KG, Brynildsen MP. 2015. Stationary-phase persisters to oﬂoxacin
sustain DNA damage and require repair systems only during recovery.
mBio 6:e00731-15. https://doi.org/10.1128/mBio.00731-15.
83. Abraham T, Prenner EJ, Lewis RNAH, Mant CT, Keller S, Hodges RS,
McElhaney RN. 2014. Structure-activity relationships of the antimicrobial
peptide gramicidin S and its analogs: aqueous solubility, self-association,
conformation, antimicrobial activity and interaction with model lipid
membranes. Biochim Biophys Acta 1838:1420–1429. https://doi.org/10
.1016/j.bbamem.2013.12.019.
84. Goodall MC. 1970. Structural effects in the action of antibiotics on the
Modes of Action of Tyrocidines and Gramicidin S ®
September/October 2018 Volume 9 Issue 5 e00802-18 mbio.asm.org 19
 o
n
 M
ay 9, 2019 by guest
http://m
bio.asm
.org/
D
ow
nloaded from
 
ion permeability of lipid bilayers. II. Kinetics of tyrocidine B. Biochim
Biophys Acta 219:28–36. https://doi.org/10.1016/0005-2736(70)90058-1.
85. Epand RF, Schmitt MA, Gellman SH, Epand RM. 2006. Role of membrane
lipids in the mechanism of bacterial species selective toxicity by two
/-antimicrobial peptides. Biochim Biophys Acta 1758:1343–1350.
https://doi.org/10.1016/j.bbamem.2006.01.018.
86. Epand RF, Mowery BP, Lee SE, Stahl SS, Lehrer RI, Gellman SH, Epand RM.
2008. Dual mechanism of bacterial lethality for a cationic sequence-
random copolymer that mimics host-defense antimicrobial peptides. J
Mol Biol 379:38–50. https://doi.org/10.1016/j.jmb.2008.03.047.
87. Epand RM, Epand RF. 2009. Lipid domains in bacterial membranes and
the action of antimicrobial agents. Biochim Biophys Acta 1788:289–294.
https://doi.org/10.1016/j.bbamem.2008.08.023.
88. Jean-François F, Castano S, Desbat B, Odaert B, Roux M, Metz-Boutigue
M-H, Dufourc EJ. 2008. Aggregation of cateslytin -sheets on negatively
charged lipids promotes rigid membrane domains. A new mode of
action for antimicrobial peptides? Biochemistry 47:6394–6402. https://
doi.org/10.1021/bi800448h.
89. Cruzeiro-Hansson L, Mouritsen OG. 1988. Passive ion permeability of
lipid membranes modelled via lipid-domain interfacial area. Biochim
Biophys Acta 944:63–72. https://doi.org/10.1016/0005-2736(88)90316-1.
90. Kaprel’iants AS, Nikiforov VV, Miroshnikov AI, Snezhkova LG, Eremin VA,
Ostrovskiı˘ DN. 1977. Membranes of bacteria and mechanism of action of
the antibiotic gramicidin S. Biokhimiia 42:329–337.
91. Loll PJ, Upton EC, Nahoum V, Economou NJ, Cocklin S. 2014. The high
resolution structure of tyrocidine A reveals an amphipathic dimer. Biochim
Biophys Acta 1838:1199–1207. https://doi.org/10.1016/j.bbamem.2014.01
.033.
92. Troskie AM. 2014. Tyrocidines, cyclic decapeptides produced by soil
bacilli, as potent inhibitors of fungal pathogens. Stellenbosch University,
Stellenbosch, South Africa.
93. Munyuki G, Jackson GE, Venter GA, Kover KE, Szilagyi L, Rautenbach M,
Spathelf BM, Bhattacharya B, van der Spoel D. 2013. Beta-sheet struc-
tures and dimer models of the two major tyrocidines, antimicrobial
peptides from Bacillus aneurinolyticus. Biochemistry 52:7798–7806.
https://doi.org/10.1021/bi401363m.
94. Andrews CT, Campbell BA, Elcock AH. 2017. Direct comparison of amino
acid and salt interactions with double-stranded and single-stranded
DNA from explicit-solvent molecular dynamics simulations. J Chem The-
ory Comput 13:1794–1811. https://doi.org/10.1021/acs.jctc.6b00883.
95. Hancock REW, Rozek A. 2002. Role of membranes in the activities of
antimicrobial cationic peptides. FEMS Microbiol Lett 206:143–149.
https://doi.org/10.1111/j.1574-6968.2002.tb11000.x.
96. Lohner K, Prenner EJ. 1999. Differential scanning calorimetry and X-ray
diffraction studies of the speciﬁcity of the interaction of antimicrobial
peptides with membrane-mimetic systems. Biochim Biophys Acta 1462:
141–156. https://doi.org/10.1016/S0005-2736(99)00204-7.
97. White DC, Frerman FE. 1968. Fatty acid composition of the complex
lipids of Staphylococcus aureus during the formation of the membrane-
bound electron transport system. J Bacteriol 95:2198–2209.
98. Te Winkel JD, Gray DA, Seistrup KH, Hamoen LW, Strahl H. 2016. Analysis
of antimicrobial-triggered membrane depolarisation using voltage sen-
sitive dyes. Front Cell Dev Biol 4:29. https://doi.org/10.3389/fcell.2016
.00029.
99. Stern A, Gibbons WA, Craig LC. 1968. A conformational analysis of
gramicidin S-A by nuclear magnetic resonance. Proc Natl Acad Sci U S A
61:734–741. https://doi.org/10.1073/pnas.61.2.734.
Wenzel et al. ®
September/October 2018 Volume 9 Issue 5 e00802-18 mbio.asm.org 20
 o
n
 M
ay 9, 2019 by guest
http://m
bio.asm
.org/
D
ow
nloaded from
 
